Fundraising FoxV-Bio Ventures
Venture capitalGhent · Seed–Growth · 13 people tracked
Also known as V-Bio
Find your way into V-Bio Ventures
Each arrow is one introduction. Sign up to fill in the first one.
Ask Jérôme Van Biervliet to introduce you to Aurelie Nowack
You →Jérôme · together at V-Bio Ventures →Aurelie
Ask Jamie Chen to introduce you to Ward Capoen
You →Jamie · together at Sibylla →Ward
Ask Sam Okafor to introduce you to Christina Takke
You →Sam · together at OCTIMET Oncology NV →Christina
- Shelley Margetson161 people can intro you
- Mathias Falcenberg124 people can intro you
- Martin Solleveld83 people can intro you
Sign up to find every way you can get introduced to V-Bio Ventures
- Your email: who you already know at V-Bio Ventures, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the V-Bio Ventures team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
V-Bio Ventures backs private life science companies with differentiated technologies that address unmet needs and offer high societal or environmental impact potential. The fund focuses on therapeutics, spanning both drug discovery and drug development, and co-creates startups in addition to investing in early- to mid-stage ventures. It maintains a preferred relationship with the Belgian research institute VIB, building some companies on VIB-derived innovation, while also sourcing deals from other research institutes, entrepreneurial initiatives, and corporate spin-outs. The firm concentrates geographically on Europe and offers more than capital through its network and sector expertise.
Source: firm website, verified Aug 7, 2026.
Team · 13 people
from the firm's website & public directories
What they invest in
from 20 of 23 portfolio companiesBiotech ×19Healthtech ×10Deep Tech ×9Medical Devices ×9AI & Machine Learning ×4AgTech ×3Digital Health ×3Longevity ×2
HQs:Belgium×7France×3United States×2Italy×1Netherlands×1
Who they back
founder profiles across 11 portfolio companiesFounding team size:solo founder×52 founders×33 founders×14+ founders×2
Where their founders studiedfrom 11 founders with education data
Ghent University ×2
What their founders studiedfrom 12 founders with field-of-study data
Life Sciences ×7Engineering ×2Medicine ×2
Where their founders worked beforefrom 15 founders with career history
VIB ×4European Research Council (ERC) ×2Sanofi ×2
Investments · 23 tracked
founders shown can be your intro pathBy year:2024 · 22023 · 12022 · 12020 · 37 dated
ATB Therapeutics is a biotech company developing bispecific antibody therapies and related immunological treatments.
BiotechHealthtechMedical Devices
Dr. Mark Throsby(Chief Executive Officer)
Co-investorsMRL Ventures FundVIVES PartnersEQT Life SciencesSambrinvestWallonie EntreprendreEQT
Corteria Pharma develops interceptive therapies aimed at treating subpopulations of patients with heart failure, sarcopenia, and obesity.
BiotechDigital HealthHealthtechLongevity
Philip JaniakinMarie-Laure OzouxinRégis OlivierinFrancesca C. LawsonMark KowalaEleonore Jouannyin
Co-investorsFountain Healthcare PartnersJeito CapitalKurma PartnersOrbiMedOmnes CapitalInvivo Capital Partners+1 more
ExeVir develops multi-specific VHH antibody therapies to treat infectious diseases, immunological conditions, and oncology, with a focus on immunocompromised populations.
BiotechDeep TechDigital HealthHealthtechMedical DevicesGhent, BE
Xavier Saelens(Scientific Founder)Nico Callewaert(Scientific Founder)inMike Garrett(Chief Executive Officer)
Co-investorsSambrinvestUCB VenturesVIBFund+VIVES Partners
Protealis breeds legume crops such as soybeans and yellow peas and develops proprietary seed coatings with nitrogen-fixing bacteria adapted to the European climate.
AgTechBiotechFoodTechGent, BE
Benjamin Laga(Co-founder & CEO)inJonas Aper(Co-founder & Director of Breeding)in
Co-investorsAgri Investment FundInnovation IndustriesKorysEstari GroupVIBPMV+1 more
Sibylla Biotech develops PPI-FIT, a drug discovery technology that uses quantum physics and mathematical modeling to characterize protein folding pathways at atomic resolution.
AI & Machine LearningBiotechDeep TechTrento, IT
Emiliano Biasini(Co-founder)inPietro Faccioli(Co-founder)inGiovanni Spagnolli(Co-founder, CTO)inMaria Letizia Barreca(Co-founder)inGraziano Lolli(Co-founder)
Co-investors3B Future Health FundCDP Venture CapitalSeroba Life SciencesVertis SGRVI PartnersClaris Ventures+1 more
Agomab is a clinical-stage biopharmaceutical company developing disease-modifying therapies for fibro-inflammatory and fibrotic diseases with high unmet medical need.
BiotechHealthtechMedical DevicesAntwerp, BE
Tim Knotnerus(Chief Executive Officer)in
Co-investorsEQT Life SciencesAdBio partnersAndera PartnersAsabys PartnersCanaan PartnersPontifax Venture Capital+1 more
Aneta operates an email-based AI research service that runs 15 specialized agents across academic, market, technical, and legal sources for days to produce long, citation-backed research reports.
AI & Machine LearningEnterprise SoftwareSaaS
Co-investorsPebblebedAndera PartnersBGVForbionFountain Healthcare PartnersHTGF+2 more
Animab develops proprietary antibodies that mimic natural intestinal protection mechanisms to safeguard piglets' health during post-weaning, a critical period in livestock production.
AgTechBiotechDeep TechHealthtechGhent, BE
Vikram Virdi(Chief Science Officer & Scientific Co-Founder)inAnn DepickerNico CallewaertEric CoxHenri De GreveAlain Wille(CEO)in
Co-investorsAgri Investment FundSeventure PartnersPMVQbic FundAIFVIB
Aphea.Bio develops bioinsecticides targeting sap-sucking insects that damage crops, in partnership with Bayer to accelerate their development.
AgTechBiotech
Isabel Vercauterenin
Co-investorsAstanor VenturesEuropean Circular Bioeconomy FundInnovation IndustriesPMVVIVES PartnersAIF+2 more
Arc Therapeutics is a stealth-stage biopharmaceutical company developing medicines for central nervous system (CNS) conditions with high unmet medical needs.
BiotechHealthtech
Co-investors+ND Capital
Astrivax Therapeutics is a clinical-stage biopharmaceutical company developing immunotherapies to treat virus-driven cancers, particularly HPV16-associated cancers like cervical and head and neck cancer.
BiotechDigital HealthHealthtechMedical Devices
Hanne Callewaert(Founder)in
Augustine Therapeutics is a biotech company developing HDAC6-targeted therapies for peripheral neuropathies such as Charcot-Marie-Tooth disease and chemotherapy-induced peripheral neuropathy, as well as neurodegenerative disorders like ALS.
BiotechMedical Devices
Co-investorsAdBio partnersAsabys PartnersJeito CapitalNovo HoldingsPMVNewton Biocapital
Avidicure develops "Actibody", a triple-agonistic antibody platform built on a human IgG scaffold designed to activate the innate and adaptive immune system for treating oncology and autoimmune diseases.
AI & Machine LearningBiotech
Robert Friesen(Founder)in
Co-investorsBioGeneration VenturesEQT Life SciencesBOMCurie CapitalKurma Partners
Biodol Therapeutics is a biotech company developing proprietary FLT3 inhibitors (BDT compounds) at the preclinical stage to treat neuropathic and chronic pain, including opioid-combination indications.
BiotechMedical DevicesMontpellier, FR
Coave Therapeutics develops targeted gene therapy vectors using its proprietary ALIGATER platform to deliver therapeutic genes to specific tissues with improved safety and precision.
BiotechDeep TechHealthtechMedical DevicesParis, FR
Co-investorsFund+Kurma PartnersSeroba Life SciencesBpifranceInvusNovo Holdings+1 more
VIB is a non-profit research institute focused on strategic basic research in life sciences, operating in partnership with five Flemish universities.
BiotechDeep TechMedical DevicesGhent, BE
Jan Steyaert(Founder (Scientific))inCedric Ververken(CEO)in
Co-investorsBioGeneration VenturesCapricorn Venture PartnersFund+PMVQuest for Growth
Flindr is a biotech company developing small molecule inhibitors for cancer treatment using its ImmunoGram Drug Discovery Engine to identify novel therapeutic targets in cancer and immune cells.
AI & Machine LearningBiotechDeep TechHealthtechGhent, BE
Maarten Ligtenberg(Founder / Chief Executive Officer)Prof. Daniel Peeper(Founder)Prof. Christian Blank(Founder)
Muna Therapeutics is a biotechnology company developing therapeutics, with a focus on drug discovery involving medicinal chemistry.
BiotechDeep TechHealthtechLongevity
Rita Balice-Gordon(Founder)inJoachim Vilstrup(Head of Protein Chemistry and Structural Biology; scientific co-founder)inMichel Detheux(Chief Executive Officer & Board Director)inAnders Hinsby(Chief Operating Officer)inNiels Plath(Chief Scientific Officer)inJakob Busch-Petersen(Chief Development Officer)in
Co-investorsDroia VenturesSanofi VenturesSofinnova Partners
Developing highly selective MET kinase inhibitors (Beerse, Belgium).
Co-investorsDroia VenturesOmnes Capital
Orionis Biosciences discovers and engineers molecules that connect proteins on or within cells to reprogram disease-driving processes or activate immune responses.
BiotechDeep TechNewton, US
Nikolai Kley(Founder)inNikolai Kley, Ph.D.(Executive Officer, Director)
BoardGriet Vanpoucke, Ph.D.(Director)Steven R. Gullans, Ph.D.(Director)
Co-investorsEmpire AngelsExcel Venture ManagementSolari CapitalSolasta VenturesWessel Management
Develops electric weed control technology using high-frequency AC to destroy weeds to the roots, as an alternative to chemical herbicides.
Co-investorsAgri Investment FundOxford Investment Opportunity Network (OION)Rabo Corporate VenturingPymwymicThe Yield LabThe Yield Lab Europe
Step Pharma develops oral cancer drugs that inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1), with its lead therapeutic dencatistat in clinical development for lymphoma, solid tumors, and essential thrombocythaemia.
BiotechDeep TechMedical DevicesSaint-Genis-Pouilly, FR
Alain Fischer(Founding Scientist)
Co-investorsHadean VenturesKurma PartnersBpifrancePontifax Venture CapitalSunstone Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
PRECIRIX NV
Portfolio news
latest coverage across their companiesAphea · agfundernews.com · Jun 11, 2026
Step Pharma · biospace.com · Oct 16, 2025
Avidicure · avidicure.com · Jun 27, 2025
Frequently asked questions
- How many investments has V-Bio Ventures made?
- V-Bio Ventures has 23 tracked investments, including 1 dated in the last 24 months.
- What stage does V-Bio Ventures invest at?
- V-Bio Ventures invests at the Seed, Series A, Series B, Growth stages.
- What is V-Bio Ventures's typical check size?
- V-Bio Ventures typically writes checks of $270K – $2.2M.
- What sectors does V-Bio Ventures focus on?
- V-Bio Ventures focuses on AgTech, Biotech, Healthtech, Longevity, Medical Devices.
- Where is V-Bio Ventures located?
- V-Bio Ventures is headquartered in Ghent, BE.
- Who does V-Bio Ventures co-invest with?
- V-Bio Ventures most often shares deals with PMV, Fund+, Kurma Partners, among 49 tracked co-investors.
Images
Similar investors
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
LIFTT is a venture capital holding company focused on deep tech technologies, using an operational, multi-vertical approach aimed at generating impact. It works to transform scientific research into high-impact companies, accelerating the path from lab to market.
Harmonix is an early-stage venture capital firm focused on advancing human health and quality of life by backing entrepreneurs and companies in healthcare, life sciences, and deep tech.